Signal transduction pathways activated by cholinergic and alpha 1-adrenergic agonists in the lacrimal gland.
Dartt
D A
DA
Schepens Eye Research Institute, Boston, Massachusetts, USA.
Hodges
R R
RR
Zoukhri
D
D
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D005089:Exocytosis; D006801:Humans; D007765:Lacrimal Apparatus / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D008954:Models, Biological; D010275:Parasympathetic Nervous System / Q000502:physiology; D011493:Protein Kinase C / Q000378:metabolism; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology*; D011976:Receptors, Muscarinic / Q000502:physiology; D015398:Signal Transduction; D013564:Sympathetic Nervous System / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D018340:Receptors, Adrenergic, alpha-1; D011976:Receptors, Muscarinic; D011493:Protein Kinase C